Intuitive Surgical Inc (ISRG)
545.65
-4.97
(-0.90%)
USD |
NASDAQ |
Nov 22, 12:18
Intuitive Surgical Enterprise Value: 191.98B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 191.98B |
| November 20, 2024 | 188.85B |
| November 19, 2024 | 187.78B |
| November 18, 2024 | 185.22B |
| November 15, 2024 | 183.79B |
| November 14, 2024 | 187.42B |
| November 13, 2024 | 187.02B |
| November 12, 2024 | 187.16B |
| November 11, 2024 | 186.69B |
| November 08, 2024 | 186.93B |
| November 07, 2024 | 182.60B |
| November 06, 2024 | 179.49B |
| November 05, 2024 | 179.36B |
| November 04, 2024 | 176.60B |
| November 01, 2024 | 176.21B |
| October 31, 2024 | 175.32B |
| October 30, 2024 | 178.86B |
| October 29, 2024 | 179.76B |
| October 28, 2024 | 177.83B |
| October 25, 2024 | 177.97B |
| October 24, 2024 | 178.09B |
| October 23, 2024 | 178.43B |
| October 22, 2024 | 180.19B |
| October 21, 2024 | 180.67B |
| October 18, 2024 | 181.49B |
| Date | Value |
|---|---|
| October 17, 2024 | 164.60B |
| October 16, 2024 | 165.61B |
| October 15, 2024 | 166.28B |
| October 14, 2024 | 169.55B |
| October 11, 2024 | 168.54B |
| October 10, 2024 | 168.21B |
| October 09, 2024 | 170.54B |
| October 08, 2024 | 167.12B |
| October 07, 2024 | 163.71B |
| October 04, 2024 | 167.53B |
| October 03, 2024 | 166.71B |
| October 02, 2024 | 169.20B |
| October 01, 2024 | 168.53B |
| September 30, 2024 | 170.85B |
| September 27, 2024 | 165.61B |
| September 26, 2024 | 168.15B |
| September 25, 2024 | 167.46B |
| September 24, 2024 | 167.46B |
| September 23, 2024 | 169.12B |
| September 20, 2024 | 168.10B |
| September 19, 2024 | 169.46B |
| September 18, 2024 | 166.64B |
| September 17, 2024 | 167.08B |
| September 16, 2024 | 169.95B |
| September 13, 2024 | 169.40B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
39.73B
Minimum
Mar 23 2020
191.98B
Maximum
Nov 21 2024
98.60B
Average
92.56B
Median
Mar 08 2022
Enterprise Value Benchmarks
| Abbott Laboratories | 210.81B |
| Becton Dickinson & Co | 83.11B |
| Masimo Corp | 9.669B |
| PROCEPT BioRobotics Corp | 4.965B |
| Perspective Therapeutics Inc | -63.40M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 565.10M |
| Revenue (Quarterly) | 2.038B |
| Total Expenses (Quarterly) | 1.461B |
| EPS Diluted (Quarterly) | 1.56 |
| Gross Profit Margin (Quarterly) | 67.41% |
| Profit Margin (Quarterly) | 27.73% |
| Earnings Yield | 1.14% |
| Operating Earnings Yield | 1.05% |
| Normalized Earnings Yield | 1.140 |